Manifestasi Neurooftalmologi pada Penyakit Parkinson dan Gangguan Gerak Lainnya
DOI:
https://doi.org/10.55175/cdk.v49i3.205Keywords:
diagnosis, gangguan gerak, neurooftalmologiAbstract
Gangguan gerak merupakan kondisi kelainan neurologis yang memengaruhi kecepatan, kelancaran, kualitas, dan kemudahan bergerak. Gejala okular umumnya ditemukan pada pasien gangguan gerak, termasuk gangguan gerak bola mata dan persepsi visual. Variasi gangguan gerak bola mata dapat bersifat karakteristik dan membantu diagnosis pasien dengan gangguan gerak.
Movement disorder is one of the neurological disorders with broad manifestations affecting speed, fl ue ncy, and quality of movement. Ophthalmological symptoms are common findings in patients with movement disorders, including abnormalities in ocular motility and visual perception. The variations of ocular abnormalities can be characterized and aid to diagnose movement disorders.
Downloads
References
Shipton EA. Movement disorders and neuromodulation. Neurol Res Int. 2012;2012:309431. doi: 10.1155/2012/309431.
Rooks MG, GarrettWS. 2016. 乳鼠心肌提取 HHS Public Access. Physiol Behav. 2017;176(3):139–48.
Jung I, Kim JS. Abnormal eye movements in parkinsonism and movement disorders. J Mov Disord. 2019;12(1):1–13.
Termsarasab P, Thammongkolchai T, Rucker JC, Frucht SJ. The diagnostic value of saccades in movement disorder patients: A practical guide and review. J Clin Mov Disord. 2015;2(1):1–10. http://dx.doi.org/10.1186/s40734-015-0025-4
Puri S, Shaikh AG. Basic and translational neuro-ophthalmology of visually guided saccades: Disorders of velocity. Expert Rev Ophthalmol. 2017;12(6):457–73.
Borm CDJM, Smilowska K, De Vries NM, Bloem BR, Theelen T. How I do it: The neuro-ophthalmological assessment in Parkinson’s disease. J Parkinsons Dis. 2019;9(2):427–35.
Armstrong RA. Visual signs and symptoms of multiple system atrophy. Clin Exp Optom. 2014;97(6):483–91.
Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: Clinical and laboratory features in 30 patients. Mov Disord. 2008;23(7):977–84.
Phokaewvarangkul O, Bhidayasiri R. How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. Transl Neurodegener. 2019;8(1):1–14.
Iankova V, Respondek G, Saranza G, Painous C, Cámara A, Compta Y, et al. Video-tutorial for the movement disorder society criteria for progressive supranuclear palsy. Park Relat Disord. 2020;78:200–3. https://doi.org/10.1016/j.parkreldis.2020.06.030
Martino D, Stamelou M, Bhatia KP. The differential diagnosis of Huntington’s disease like syndromes: “Red flags” for the clinician. J Neurol Neurosurg Psychiatry 2013;84(6):650–6.
Winder JY, Roos RAC. Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice. PLoS One 2018;13(3):1–8.
Tan AH, Toh TH, Low SC, Fong SL, Chong KK, Lee KW, et al. Chorea in Sporadic Creutzfeldt-Jakob Disease. J Mov Disord. 2018;11(3):149–51.
Orrù CD, Soldau K, Cordano C, Llibre-Guerra J, Green AJ, Sanchez H, et al. Prion seeds distribute throughout the eyes of sporadic Creutzfeldt-Jakob disease patients. MBio. 2018;9(6):e02095-18. doi: 10.1128/mBio.02095-18.
Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Ophthalmic features of Friedreich ataxia. Eye 2012;26(2):315–20. http://dx.doi.org/10.1038/eye.2011.291
Park JY, Joo K, Woo SJ. Ophthalmic manifestations and genetics of the polyglutamine autosomal dominant spinocerebellar ataxias: A review. Front Neurosci. 2020;14:892.
Dusek P, Litwin T, Członkowska A. Neurologic impairment in Wilson disease. Ann Transl Med. 2019;7(S2):64.
Goel S, Sahay P, Maharana PK, Titiyal JS. Ocular manifestations of Wilson’s disease. BMJ Case Rep. 2019;12(3):10–2.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
